An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a pandemic. The impact on the medical community has been huge, not only on the front-line, but also for patients navigating treatment for neurological conditions during this unprecedented situation.
The touchHAEMATOLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Our supporting partners do not constitute an endorsement of the content on this page.
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
In this interview, touchHAEMATOLOGY are joined by Professor Per Ljungman (Karolinska University Hospital, Stockholm, Sweden) to discuss the updated results of the EBMT COVID-19 Task Force study exploring study exploring the outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19. Questions 1. Please describe the rationale and main aims of your […]
Journal articles and more to your inbox
Get the latest clinical insights from touchHAEMATOLOGYSign me up!